Study for Efficacy and Dose Escalation of AD313 + Atomoxetine (SEED)

Clinical trial NCT05101122 · COMPLETED

Trial details

NCT number: NCT05101122
Sponsor: Apnimed
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Obstructive Sleep Apnea

Start date: 2021-10-19
Primary completion: 2022-04-18
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.